GlobalData's Medical Devices sector report, "
Bare Metal Stents (BMS) - Medical Devices Pipeline Assessment, 2016" provides an overview of
Bare Metal Stents (BMS) currently in pipeline stage.
Through its selection of EdgePresence, the company will be able to provide its services along with
bare metal colocation solutions for enterprise businesses in edge markets throughout the US EdgePresence solutions are highly scalable providing access to robust low latency network connectivity including transit and transport services from each EdgePod(TM) location.
"Using drug-eluting stents over
bare metal stents in these lesions is the appropriate thing to do."
With a disk-to-disk backup and disaster recovery solution, users can recover files in the time it takes to browse to them through Windows, and perform
bare metal recovery in the time it takes to copy a file from the network.
The inflammatory responses and biocompatibility observed with CV Therapeutics' technology in preclinical studies are similar to results seen with
bare metal stents.
Food and Drug Administration (FDA) in December 2006 warns that high-risk patients who receive drug-eluting stents may be more likely to suffer serious clots long after the stents were put in, compared to those with older and cheaper
bare metal stents.
Stents come in two forms:
bare metal, or coated with drugs designed to keep the arteries from re-clogging.
In year 1, initially the risk was lower in the group with drug-eluting stents than in the group with
bare metal stents.
Results from the Swedish study of nearly 48,000 patients now suggest the devices work as promised, especially in high-risk patients, who had a 74% lower risk of having a clogged stent compared with similar patients who got a
bare metal stent.
"Outcomes from prior registry and randomised trials of drug-eluting stents compared to
bare metal stents in heart attack patients have been conflicting.
The endothelial progenitor cell capture stent provides an excellent alternative to
bare metal stents for the treatment of these challenging lesions." The paper, titled "One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent," is based on a single-center, non-randomized study.